Guide
Transmission Risk: The Actual Numbers
What daily antivirals + condoms actually reduce HSV transmission risk to. HSV-1 vs HSV-2. Male-to-female vs female-to-male. The data, not the fear.
The short answer: With daily suppressive antivirals (like valacyclovir) + consistent condom use, the annual transmission risk for HSV-2 is around 2% (female-to-male) or 4% (male-to-female). For HSV-1 genital, it's even lower. No sexual activity is zero-risk, but these numbers are comparable to many other STIs people accept without stigma.
This guide breaks down the actual data, what reduces risk, and how to interpret the numbers when talking to a partner.
The baseline (no precautions)
Without any suppressive medication or condoms, here's the annual transmission risk for HSV-2 in heterosexual couples where one partner is positive and the other is negative:
| Direction | Annual risk (no precautions) |
|---|---|
| Male to female | ~10% |
| Female to male | ~4% |
Source: Corey et al., NEJM 2004; Mertz et al., JAMA 2008
Why the difference? Female anatomy has more mucosal surface area exposed during sex, which slightly increases susceptibility. This same pattern holds for many STIs.
What suppressive therapy does
Daily suppressive antiviral medication (typically valacyclovir 500mg once daily) reduces transmission risk by approximately 50%. This is based on the landmark study by Corey et al. (2004) published in the New England Journal of Medicine.
With daily antivirals alone (no condoms):
- Male to female: ~10% → ~5% per year
- Female to male: ~4% → ~2% per year
How it works: Suppressive therapy reduces viral shedding (when the virus is active on the skin but not causing visible symptoms). Less shedding = lower transmission risk, even between outbreaks.
What condoms do
Condoms reduce HSV-2 transmission risk by approximately 30–50%, depending on the study. They're not perfect (HSV can infect areas the condom doesn't cover), but they still provide meaningful protection.
Source: Martin et al., Sexually Transmitted Diseases 2009
Combined: antivirals + condoms
When you stack both interventions — daily suppressive antivirals and consistent condom use — the annual transmission risk drops to:
- Male to female: ~4% per year
- Female to male: ~2% per year
Precautions cut the yearly risk by more than half
Two ladders per scenario · dark rungs = male to female · pale rungs = female to male · one rung = one percentage point of risk per year
Paired rungs · HSV-2 serodiscordant couples · Corey 2004 · Mertz 2008 · Martin 2009
This is not zero, but it's low. For context:
- The annual risk of chlamydia with condoms: ~3–5% (CDC estimates)
- The annual risk of HPV transmission even with condoms: ~10–20% (most people accept this without stigma)
No sexual activity is risk-free. The question is whether the risk is acceptable given the precautions and the relationship context. For many people, 2–4% per year is.
HSV-1 genital vs. HSV-2
HSV-1 genital (the cold-sore virus in a different location) has significantly lower transmission risk than HSV-2 genital. Why? HSV-1 prefers oral tissue; when it's genital, it sheds less frequently and causes fewer recurrent outbreaks.
| Type | Transmission risk (with precautions) |
|---|---|
| HSV-2 genital | 2–4% per year |
| HSV-1 genital | ~1% per year (estimated) |
| HSV-1 oral (cold sores) | Variable; low outside outbreaks |
If you have genital HSV-1, your transmission risk is lower than the HSV-2 numbers above. Many doctors don't emphasize this enough.
What about asymptomatic shedding?
Asymptomatic shedding is when the virus is active on the skin but not causing visible symptoms. This is how most HSV transmission happens — not during outbreaks, but between them.
For HSV-2 genital:
- Shedding occurs on ~15–20% of days without antivirals.
- With daily suppressive therapy, shedding drops to ~5–10% of days.
For HSV-1 genital:
- Shedding occurs on ~3–5% of days (much less frequent).
Source: Tronstein et al., JAMA 2011
This is why suppressive therapy works — it reduces the days when transmission is even possible.
Avoiding sex during outbreaks
This one's obvious, but it's worth stating: Do not have sexual contact during an active outbreak. The viral load is highest when lesions are present, and transmission risk is orders of magnitude higher.
Avoid contact from the moment you feel prodrome symptoms (tingling, itching, discomfort) until the lesion has completely healed and the skin looks normal again.
How to talk about these numbers
When disclosing, keep it simple:
"With daily antivirals and condoms, transmission risk is around 2–4% per year. That means if we're together for a year, there's a 96–98% chance you won't get it. No sex is zero-risk, but this is comparable to other STIs people accept."
If they want more detail, point them here or to the CDC's HSV fact sheet. But most people just need the headline number and the reassurance that you're managing it responsibly.
What if they do contract it?
Even with precautions, transmission can happen. If a partner contracts HSV from you:
- Most people have mild or no symptoms. Up to 80% of people with HSV-2 don't know they have it because their outbreaks are rare or asymptomatic.
- It's manageable. Daily antivirals, lifestyle adjustments, and knowing your triggers keep most people outbreak-free or near-outbreak-free.
- It's not life-altering. The stigma is worse than the virus itself. Most people who've had HSV for a few years report it barely affects their life.
That said, this is why informed consent matters. Your partner deserves to know the risk upfront so they can decide if it's acceptable to them.
The bottom line
With daily suppressive antivirals and consistent condom use, annual HSV-2 transmission risk is 2–4%. For HSV-1 genital, it's even lower. No sexual activity is zero-risk, but these numbers are low and comparable to other accepted STIs.
You're not endangering someone by dating them. You're giving them informed consent and taking responsible precautions. That's all anyone can ask.